A Single-Center Pilot Study to Assess Macular Function

Completed

• Conditions: Macular Degeneration

• Registration Number: NCT01204541
• Lead Sponsor: ORA, Inc.

Brief Summary

This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09
• Study First Submitted: 2010-09-16
• Study First Submitted QC: 2010-09-16
• Study First Posted: 2010-09-17
• Primary Completion: 2010-10
• Study Completion: 2010-10
• Status Verified: 2012-02
• Last Update Submitted: 2012-02-13
• Last Update Posted: 2012-02-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
• Subjects with early non-exudative age-related macular degeneration (AMD cohort)

Exclusion Criteria

• Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified